Bank of America’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$706K Buy
149,471
+27,909
+23% +$132K ﹤0.01% 4632
2025
Q1
$558K Sell
121,562
-6,774
-5% -$31.1K ﹤0.01% 4677
2024
Q4
$615K Buy
128,336
+28,659
+29% +$137K ﹤0.01% 4571
2024
Q3
$467K Buy
99,677
+22,259
+29% +$104K ﹤0.01% 4700
2024
Q2
$437K Sell
77,418
-1,130,843
-94% -$6.39M ﹤0.01% 4657
2024
Q1
$4.97M Buy
1,208,261
+1,181,116
+4,351% +$4.85M ﹤0.01% 3061
2023
Q4
$115K Sell
27,145
-15,334
-36% -$64.7K ﹤0.01% 5408
2023
Q3
$184K Sell
42,479
-296,446
-87% -$1.28M ﹤0.01% 5084
2023
Q2
$2.23M Sell
338,925
-1,292,215
-79% -$8.52M ﹤0.01% 3471
2023
Q1
$11.1M Buy
1,631,140
+1,345,529
+471% +$9.14M ﹤0.01% 2335
2022
Q4
$2.11M Sell
285,611
-62,314
-18% -$461K ﹤0.01% 3622
2022
Q3
$3.44M Sell
347,925
-130,784
-27% -$1.29M ﹤0.01% 3181
2022
Q2
$5.22M Buy
478,709
+167,879
+54% +$1.83M ﹤0.01% 2877
2022
Q1
$3.52M Sell
310,830
-77,220
-20% -$873K ﹤0.01% 3466
2021
Q4
$6.09M Buy
388,050
+80,274
+26% +$1.26M ﹤0.01% 2949
2021
Q3
$5.28M Buy
307,776
+29,713
+11% +$509K ﹤0.01% 3019
2021
Q2
$5.98M Buy
278,063
+25,551
+10% +$550K ﹤0.01% 2896
2021
Q1
$3.79M Buy
252,512
+33,549
+15% +$504K ﹤0.01% 3244
2020
Q4
$2.88M Sell
218,963
-71,805
-25% -$944K ﹤0.01% 3125
2020
Q3
$2.81M Buy
290,768
+47,367
+19% +$458K ﹤0.01% 2997
2020
Q2
$2.79M Buy
243,401
+8,442
+4% +$96.6K ﹤0.01% 2986
2020
Q1
$2.44M Buy
234,959
+42,779
+22% +$443K ﹤0.01% 2962
2019
Q4
$3.15M Sell
192,180
-33,829
-15% -$555K ﹤0.01% 3132
2019
Q3
$3M Sell
226,009
-243,589
-52% -$3.23M ﹤0.01% 3131
2019
Q2
$6.62M Sell
469,598
-151,052
-24% -$2.13M ﹤0.01% 2524
2019
Q1
$11.4M Buy
620,650
+314,638
+103% +$5.79M ﹤0.01% 2043
2018
Q4
$8M Sell
306,012
-21,618
-7% -$565K ﹤0.01% 2177
2018
Q3
$7.52M Buy
327,630
+137,694
+72% +$3.16M ﹤0.01% 2405
2018
Q2
$3.62M Buy
189,936
+6,040
+3% +$115K ﹤0.01% 2984
2018
Q1
$3.1M Buy
183,896
+14,741
+9% +$248K ﹤0.01% 3051
2017
Q4
$2.57M Sell
169,155
-22,129
-12% -$336K ﹤0.01% 3194
2017
Q3
$3.43M Buy
191,284
+73,034
+62% +$1.31M ﹤0.01% 3022
2017
Q2
$1.93M Buy
118,250
+48,435
+69% +$789K ﹤0.01% 3364
2017
Q1
$977K Buy
69,815
+9,439
+16% +$132K ﹤0.01% 3821
2016
Q4
$963K Buy
60,376
+23,071
+62% +$368K ﹤0.01% 3722
2016
Q3
$621K Buy
37,305
+899
+2% +$15K ﹤0.01% 3813
2016
Q2
$407K Buy
36,406
+17,514
+93% +$196K ﹤0.01% 4062
2016
Q1
$158K Sell
18,892
-12,568
-40% -$105K ﹤0.01% 4485
2015
Q4
$293K Buy
31,460
+44
+0.1% +$410 ﹤0.01% 4219
2015
Q3
$354K Sell
31,416
-27,852
-47% -$314K ﹤0.01% 4117
2015
Q2
$752K Buy
59,268
+2,761
+5% +$35K ﹤0.01% 3504
2015
Q1
$526K Buy
56,507
+47,864
+554% +$446K ﹤0.01% 3436
2014
Q4
$124K Sell
8,643
-5,778
-40% -$82.9K ﹤0.01% 4431
2014
Q3
$149K Buy
14,421
+281
+2% +$2.9K ﹤0.01% 4263
2014
Q2
$229K Buy
14,140
+6,194
+78% +$100K ﹤0.01% 4124
2014
Q1
$129K Sell
7,946
-111,302
-93% -$1.81M ﹤0.01% 4339
2013
Q4
$1.48M Sell
119,248
-122,674
-51% -$1.52M ﹤0.01% 2789
2013
Q3
$2.65M Buy
241,922
+1,731
+0.7% +$19K ﹤0.01% 2242
2013
Q2
$1.94M Buy
+240,191
New +$1.94M ﹤0.01% 2502